Business · 16/06/2025

FDA Releases Final Guidance on Pre-Submission Facility Correspondence for Prioritized Generic Drug Submissions

The FDA has announced the availability of a final guidance for industry on pre-submission facility correspondence related to prioritized generic drug submissions, which outlines the facility information to be submitted and how the FDA will use it to set review goals for priority ANDAs.